{
    "Trade/Device Name(s)": [
        "TRUENESS\u2122 AIR Blood Glucose Monitoring System",
        "TRUENESS\u2122 Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Sinocare Inc.",
    "510(k) Number": "K231476",
    "Predicate Device Reference 510(k) Number(s)": [
        "K193407"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "December 1, 2023",
    "Summary Letter Received Date": "May 22, 2023",
    "Submission Date": "May 22, 2023",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "TRUENESS\u2122 Blood Glucose Meter",
        "TRUENESS\u2122 AIR Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor"
    ],
    "Methodologies": [
        "Electrochemical"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for TRUENESS\u2122 AIR and TRUENESS\u2122 Blood Glucose Monitoring Systems for quantitative glucose measurement in capillary whole blood.",
    "Indications for Use Summary": "For quantitative measurement of glucose in capillary whole blood from the finger for diabetes management at home by a single user; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}